{"sourcedb":"DevicePMAs@therightstef","sourceid":"P140031_S028","text":"Approval for the SAPIEN 3 Transcatheter Heart Valve and accessories.  The device is indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i. e., predicted risk of surgical mortality greater than or equal to 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).","project":"consensus_PMA_Age_Indications"}